Guest guest Posted August 20, 2011 Report Share Posted August 20, 2011 What's New Digest - August 20, 2011 By Anjou for PAL News and Reports: www.lymphomation.org/current.htm OR www.facebook.com/lymphomation.PAL (requires facebook account) === Survivorship NY Times: Finding a quality doctor NCI: Facing Forward: Life After Cancer Treatment WSJ: For Cancer Patients, Help Navigating the Maze MD: Taking the time to answer patient questions Philly.com: Studying the positive side of Trauma and Grief My Cancer Advisor: Should you get a second opinion My Cancer Advisor: Preparing for hair loss after Chemo My Cancer Advisor: How Do I Get My Medical Records? MD.COM: Why developing trust with your doctor is important Medical News Today: Docs Urge Cancer Patients To Discuss Supplements Before Treatment === Reports / Background Fox Chase: IMRT improves outcomes in patients with extranodal lymphoma of the head and neck British J of Haematology: VcR-CVAD induction chemo followed by maintenance Rituxan in MCL Medical News Today: New Drug In Early Clinical Testing Offers New Hope For Treatment Of Chronic Leukemia Univ of PA press release: Triple therapy regime puts patients with leukemic form of cutaneous lymphoma in remission (Retrospective study) NEJM Early Stage Hodgkin's Is ecstasy 'being developed to treat blood cancers'? Not quite. === Videos / Webcasts National Comprehensive Cancer Network: Cancer treatment is viewed as a true partnership video Health Smart: Facing Cancer Together General cancer video Youtube: Learn about the importance of a specific subtype diagnosis in adults with NHL in this video, led by Dr. Sweetenham. === Advocacy and Notices LLS: Understanding Your Treatment Options Telephone or web conference 9/14 Our Letter on the need to amend CMS reimbursement policy for radioimmunotherapy PDF PAL endorses Betsy de Parry's Petition, which is easy to sign! Drug Shortages and How to Address! === Clinical Trials 7 Reasons to Consider Clinical Trials: based on your clinical circumstances PAL Lymphoma Studies sponsored by CALGB cooperative group - now called the ALLIANCE === PAL Updates Comments on Programming T-cells to Kill Malignant B-Lymphocytes To Port or Not to Port - and related drug administration questions (draft) PET scan - clinical use " very little is certain and agreed upon. " === Food for Thought Cancer Research UK: In the news: re-tooling the body's police force to beat leukaemia Cure today: Why is randomization in clinical trials important? Washington Post 'Comparative effectiveness research' tackles medicine's unanswered questions Clinical Oncology News 40 Years of DLBCL Give CHOP, Add Rituxan-Is that all there is? Clinical Oncology News: Is Patient Optimism unrealistic In Early-Phase Trials? Cancer Network: ASCO 2011: Steve Joffe Discusses Controversies in Phase I Clinical Trials ls of Oncology: Response criteria for NHL: Importance of 'normal' lymph node size and correlations with response rates NCI: Hyperthermia in Cancer Treatment? Medscape: Do Biologics (used for rheumatologic disease) Cause Cancer === Technical and Theory BBC Cancer discovery offers hope of tackling spread of disease Cancer Network: Novel PARP Inhibitor for Solid Tumors & Lymphomas Medical News Today: Stem Cells Central To Pathogenesis Of Mature Lymphoid Tumors University of Copenhagan: Researchers on the trail of a treatment for cancer of the immune system (EBV related blood cancers) Cancer Research: In Vivo Programming of Tumor Antigen-Specific T Lymphocytes from Pluripotent Stem Cells to Promote Cancer Immunosurveillance Data mining' to generate hypotheses for testing new indications for existing drugs. Cornell-lymphoma Blog: Cyclophosphamide may be associated with an increased risk of secondary myeloid neoplasia when given with Fludarabine in CLL Advances in Hematology: Review Article Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies NY Times: Cancer's Secrets Come Into Sharper Focus ~ Karl PATIENTS (helping-to-make-progress) AGAINST LYMPHOMA www.lymphomation.org Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.